TrialLineage Concept
Inherited retinal disease
Inherited retinal diseases are a group of genetic conditions that damage the cells responsible for vision. They range from conditions causing night blindness and peripheral vision loss to those causing near-total blindness in childhood. Understanding them as genetic disorders — rather than untreatable degenerations — opened the door to molecular therapies.
In plain language
What are inherited retinal diseases?
The retina contains millions of specialized cells — rods, cones, and supporting cells — that convert light into the neural signals we perceive as vision. Inherited retinal diseases occur when a mutation in one of the genes needed by these cells causes them to malfunction or die. Because many retinal genes are highly specialized, even a single mutation can cause progressive vision loss.
More than 270 genes are now known to cause inherited retinal disease. Conditions include retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease, achromatopsia, and many others. Each has a distinct genetic cause, progression pattern, and potential therapeutic approach.
Why this matters
Inherited retinal diseases collectively affect hundreds of thousands of people worldwide. Individually rare, they share a common feature: progressive loss of vision with historically no effective treatment. Recognizing them as genetically defined conditions transformed them from untreatable degenerations into potential targets for gene-based therapies.
The ability to identify the precise genetic mutation in each patient also enables accurate prognosis, family counseling, and — increasingly — selection for clinical trials of gene-specific treatments.
Connection to gene therapy
Inherited retinal diseases provided the clinical context for the first successful gene therapies. RPE65-associated Leber congenital amaurosis became the first condition treated with an approved gene therapy product (voretigene neparvovec). The genetic clarity of these diseases — single gene, known protein, defined cell type — made them tractable targets for gene replacement strategies.
Related concepts